GAST and gastric cancer: However, serum Helicobacter pylori antibody, pepsinogen-I, pepsinogen-II, and gastrin-17 have been widely researched and practiced in health check-up, screening, and surveillance of gastric cancer and its precancerous high-risk events, which shows promising performance in the stratification of gastric cancer risk [15,36,37].